Ketosis is a common disease of dairy cattle. It typically occurs in early lactation & is
most consistently characterized by partial anorexia & depression.
In addition to inappetence, signs of nervous dysfunction, including pica, abdominal
licking, incoordination & abnormal gait, bellowing & aggression occasionally are
seen.
This condition is worldwide in distribution, but it is most common where dairy cows
are bred & managed for high production.
ETIOLOGY & PATHOGENESIS
High glucose demand & intense adipose mobilization are causes ketosis.
Both these condition are present in early lactation, at which time negative energy
balance leads to adipose mobilization & milk synthesis creates high glucose demand.
Adipose mobilization is accompanied by high blood serum concentration of
nonesterified fatty acids(NEFA)
During period of intense gluconeogenesis, a large portion of serum NEFA is directed to
ketone body synthesis in the liver.
Ketone bodies are acetone, acetoacetate & -hydroxy butyrate (BHB).
Thus, clinicopathologic characterization of ketosis include high serum concentration of
NEFA & ketone bodies & low concentrations of glucose.
FACTORS ATTRIBUTABLE TO KETOSIS
1. Lack of nutritive feed
2. Adreno-cortical insufficiency
3. Hypothyroidism
4. Role of insulin
5. Lack of exercise
6. Hepatic insufficiency
7. Deficiency of co-enzyme A
CLINICAL FINDINGS
History
Clinical sign
Biochemical examination
Subclinical ketosis can be detected by estimation of BHB in milk. Value excess of 1-2
mg/dl will indicate about subclinical ketosis which ultimately may turn into clinical
ketosis.
DIFFERENTIAL DIAGNOSIS
1. Replacement therapy:--
The only rational treatment in ketosis is to relieve the need of glucose formation from
tissue & allow ketone body utilisation to continue normally.
The simplest means of doing this is by administration of glucose replacement
therapy.
Generally 500-800 c.c of a 40-50% solution of glucose (Dextrose solution) should be
given intravenously at once.
Oral hyperglycaemic agents should be given which maintain glucose level in blood.
ORAL HYPERGLYCAEMIC AGENTS
DKA leads to decrease the production and level of malonyl CoA Which
inhibits fatty acid oxidation
A fall in malonyl CoA levels leads to excessive fatty acid oxidation with
excessive production of acetyl CoA and excess acetoacetate.
Acetoacetic acid and beta-hydroxybutyric acid dissociate
producing H+ which is buffered by HCO3- in the blood.
For each anion produced there is a loss of one bicarbonate.
The increase in the anion gap (representing the increase in the
unmeasured acid anions) should approximately equal the
decrease in the [HCO3-].
SO A pure high anion gap metabolic acidosis results.
Complication
Hyperchloraemic metabolic acidosis develops during the treatment phase.
Acetoacetate and beta-hydroxybutyrate are moderately strong acids and
even at the lowest urinary pH are significantly ionised. They are excreted with
a cation (usually Na+ or K+) to maintain electroneutrality.
The net effect is the loss of potential bicarbonate equal to the level of urinary
ketone body loss.
The HCO3- is replaced in the blood by Cl- derived from renal reabsorption,
gut absorption or (particularly) IV saline administered during treatment.
MANAGEMENT OF DKA
DKA can be treated with potent but regular short-acting crystalline
insulin injections to help get the serum glucose levels back under
control.
Phosphate supplementation
Bicarbonate to correct acid-base disturbances
If the serum bicarbonate concentration falls below 10 mEq/l, or the pH
is less than 7.15, specific treatment with sodium bicarbonate is
necessary
IDENTIFY AND TREAT PRECIPITATING
FACTORS
Antibiotics therapy can be useful to prevent secondary Bacterial
infection.
Pancreatitis and Hyperadrenocorticism treatment also initiated to
prevent so that DKA does not recur.
Reference:-- The merck veterinary manual
Textbook of clinical veterinary medicine by Amalendu chakrabarti